About Cerebrum Matter

The idea of creating Cerebrum Matter stems from our founder’s personal experience of accompanying her grandmother through a rough journey with Parkinson’s, a decade ago. Bojan’s vision to treat early onset dementia through digital therapy has been transformed into Cerebrum Matter’s mission to reduce the prevalence of disabling symptoms for people living with dementia.

Our idea of digital healthcare came to the fore in 2016 when the company’s bootstrapping stage, leading to the idea of a therapy software highly focused on Mental well-being. The development of the software tunnelled into the R&D process by end of 2017, leading us to start working on conducting a clinical trial with people to develop an evidence-based product aiming sincerely at treating cognitive declination, depression, anger & anxiety, the logical reasoning which are considered to leading onset symptoms of dementia using brainwave analysis.

Changing the Game for Healthy Ageing

Dementia is the broad category of neurodegenerative brain diseases that includes such diseases as Alzheimer’s, vascular dementia and Lewy body dementia, etc. In the case of most progressive dementias, including Alzheimer’s disease, there is no cure and no treatment that slows or stops its progression. But there are drug treatments that may temporarily improve symptoms but of high risk prescribing them at early stages, which is not in practice.

While the use of medication is undoubtedly vital in helping both severe and light sufferers of dementia, Cerebrum Matter believes that dementia prevention is still an underdeveloped form of treatment that could potentially change the way the earlier stages of dementia are treated; if rights products and innovation are applied. While the ‘brain training’ software market is relatively crowded, Cerebrum Matter will have a clinically validated product classified as a medical device, and also with our developing advanced brainwave technology we are aiming to provide a personalised experience of cognitive improvement according to each individuals’ brain functionalities.


To prevent and reduce the prevalence of the symptoms of early onset dementia, by promoting mental wellness and thus leading to longer and higher quality independent lives to the elderly.


To become a Global leader in the field of cognitive therapy focused brainwave technology, leading to a significant reduction in the estimated numbers of future potential victims of dementia.